id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-356363-gea5229c	Kurdi, Amanj	A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?	2020-10-20		.txt	text/plain	2426	126	40	Consequently, we sought to undertake an updated and comprehensive evaluation of effect of ACEIs/ARBs use on all reported COVID-19-related outcomes, including exploration of any class differences, through a systematic review of the literature coupled with a meta-analysis. Key protein targets and ligands in this article are hyperlinked to corresponding entries in http://www.guide topha rmaco logy.org, F I G U R E 1 0 Forest plot depicting pooled estimates for the association between use of ventilator/Intensive Care Unit admission and the three levels of renin-angiotensin system drug exposure (ACEIs/ARBs, ACEIs, ARBs) Odds ratio the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY, 59 and are permanently archived in the Concise Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China Effects of angiotensin II receptor blockers and ACE (Angiotensin-Converting Enzyme) inhibitors on virus infection, inflammatory status, and clinical outcomes in patients with COVID-19 and hypertension: a single-center retrospective study A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin converting enzyme inhibitors or angiotensin receptor blockers.	./cache/cord-356363-gea5229c.txt	./txt/cord-356363-gea5229c.txt